Pharmacyte Biotech Inc. (PMCB)
NASDAQ · Healthcare
Pharmacyte Biotech Inc. Revenue 2011–2025
Pharmacyte Biotech Inc. annual/quarterly revenue history and growth rate from 2011 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Pharmacyte Biotech Inc. revenue for the quarter ending January 31, 2026 was 0.
- Pharmacyte Biotech Inc. revenue for the twelve months ending January 31, 2026 was 0.
- Pharmacyte Biotech Inc. annual revenue for 2025 was 0.
- Pharmacyte Biotech Inc. annual revenue for 2024 was 0.
- Pharmacyte Biotech Inc. annual revenue for 2023 was 0.
- Pharmacyte Biotech Inc. annual revenue for 2022 was 0.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Pharmacyte Biotech Inc. (PMCB) — Frequently Asked Questions
Pharmacyte Biotech Inc. (PMCB) is a publicly traded US company. It has a market capitalization of $5M. Explore PMCB's stock price, financial statements, earnings history, margins and key ratios below.
What is Pharmacyte Biotech Inc.'s market cap?
Pharmacyte Biotech Inc. (PMCB) has a market capitalization of $5M.
What is the PMCB stock price?
PMCB trades at $0.70.
Is PMCB profitable?
In fiscal 2025, Pharmacyte Biotech Inc. reported net income of $31M.